Le Lézard
Classified in: Health
Subjects: MAV, CCA, FVT, CFG

Notice to the media - Health Canada officials to hold a media technical briefing


OTTAWA, May 30, 2018 /CNW/ - Officials from Health Canada will hold a technical briefing to discuss the upcoming proposed re-evaluation decision on imidacloprid's effects on pollinators.

Officials will be available to answer questions from the media following a statement.

Date
May 31, 2018

Time
1:00 PM (EDT)

Location
Media Technical Briefing will be held by teleconference only at:

Toll-free (Canada/US) dial-in number:
1-866-805-7923

Passcode: 8998770#

 

SOURCE Health Canada


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
NCPDP Foundation Funds New Project to Streamline REMS Process for the Industry
Getting specialty medications into...

19 avr 2024
Arthrex Wins Both Gold and Silver Medals at 2024 Edison Awards
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Riding the Trend: Baros Maldives' Immersive Water Therapy
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
NCPDP's National Facilitator Model Pilot Project Enters Second Phase
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

More news about Health...


News published on and distributed by: